Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 5

Boehringer Starts Phase III Trial of Verducatib for COPD

Nov 2, 2026
Boehringer Ingelheim has registered a new Phase III clinical trial to evaluate verducatib, an experimental oral medicine for people living with chronic obstructive pulmonary disease…
Read More...

Adalvo Acquires Enzene’s Romiplostim Biosimilar Programme

Oct 30, 2026
Adalvo has acquired a romiplostim biosimilar programme from Indian biotechnology company Enzene Biosciences, strengthening its portfolio of complex biological medicines and marking a…
Read More...

Appian and PSI CRO Partner to Bring AI Into Clinical Trials

Oct 30, 2026
Appian and PSI CRO have formed a strategic partnership to use artificial intelligence (AI) and automation to improve clinical trial operations and speed up the drug development process.…
Read More...

Pfizer Partners With Edison Scientific to Accelerate AI-Driven Drug Research

Oct 30, 2026
Pfizer has entered into an agreement with Edison Scientific to use artificial intelligence (AI) to accelerate drug discovery and development across its biopharmaceutical research…
Read More...

Dren Bio Raises $350M to Advance Experimental Blood Cancer Drug

Oct 30, 2026
Dren Bio has raised $350 million in an oversubscribed private financing round to advance its experimental drug dibotatug towards potential commercialisation and accelerate the…
Read More...

Glenmark Opens Major US Pharmaceutical Distribution Center in Pennsylvania

Oct 30, 2026
Glenmark Pharmaceuticals has inaugurated a new distribution center in Allentown, Pennsylvania, marking an important expansion of its operations and pharmaceutical supply chain in the…
Read More...

Formation Bio Launches $600M Fund to Accelerate Drug Development

Oct 30, 2026
Formation Bio has launched a $600 million Drug Development Accelerator Fund to help promising drug candidates move through clinical development and reach patients faster. The fund…
Read More...

Enthorin Licenses Fragile X Drug Candidate ENT-7340 to Rumi

Oct 30, 2026
Enthorin Therapeutics has signed a licensing agreement with Rumi Therapeutics to advance ENT-7340, an experimental drug candidate being developed for Fragile X syndrome and other…
Read More...

Lilly’s Retatrutide Shows Greater A1C Reduction in Type 2 Diabetes Trial

Oct 30, 2026
Eli Lilly’s experimental obesity and diabetes drug retatrutide has delivered stronger blood sugar control and more than twice the weight loss compared with Novo Nordisk’s Ozempic in a…
Read More...

Twist Bioscience Launches Faster Antibody Screening Technology

Oct 28, 2026
Twist Bioscience has expanded its antibody discovery and development portfolio with the launch of Twist Express Screening Antibodies, a new high-throughput service designed to help…
Read More...
Previous 1 … 3 4 5 6 7 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.